In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...

A noninferiority study design was used to evaluate patient satisfaction and cost savings with insulin pens versus vials and syringes. Patients were randomly assigned (1:1) to receive their insulin ...

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

For millions of Americans who rely on insulin to manage their diabetes, the price surge can pose a financial burden.The ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

Medicare Part B covers diabetes test strips as a type of durable medical equipment. Learn how to qualify for coverage and ...

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

Next year’s expected rate of increase would be roughly four times the projected rate of inflation. Healthcare costs are ...

Embecta Corp. focuses on diabetes products and recently received FDA approval for a new patch pump. Read why I'm neutral on ...

The City of San Antonio and H-E-B launched the Diabetes Insulin Assistance Program to help residents struggling with the high ...

“This translates to a monthly expense of N36,000 just for syringes, not including the cost of insulin and other necessary medications. READ ALSO:World Bank plans affordable healthcare to 1.5 ...

Purpose: Patient satisfaction, safety and efficacy outcomes, and cost savings with insulin pens versus conventional insulin delivery via vials and syringes in hospitalized patients with diabetes ...